Literature DB >> 17085967

Histone deacetylation is involved in activation of CXCL10 upon IFNgamma stimulation.

Jin-Jun Guo1, Qing-ling Li, Jun Zhang, Ai-Long Huang.   

Abstract

Histone deacetylase (HDAC) activity is commonly associated with transcriptional repression. However, there is also evidence for a function in transcriptional activation. Previous studies have demonstrated a fundamental role of deacetylase activity in IFNa-responsive gene transcription. In the case of type II IFN (IFNgamma) results are controversial: some genes require HDAC activity, while transcription of others is repressed by HDAC. To investigate the effect of HDAC on transcription of an IFNgamma-activated gene, real-time PCR was used to measure CXCL10 mRNA in Hela cells stimulated with IFNgamma in the presence or absence of the HDAC inhibitor TSA. Chromatin imunoprecipitation combined with real-time PCR was used to check acetylation of histone H4 and recruitment of the STAT1 complex to the ISRE locus of the CXCL10 gene. Activation of CXCL10 transcription in response to IFNgamma was paralleled by a decrease in histone H4 acetylation and an increase in recruitment of the STAT1 complex to the CXCL10 ISRE locus. The transcription of CXCL10 and histone H4 deacetylation were blocked by TSA, but the latter had no obvious affect on recruitment of the STAT1 complex. Our data indicate that IFNgamma and STAT-dependent gene transcription requires the participation of HDAC, as does the IFNalpha-STAT pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085967

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  7 in total

1.  The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.

Authors:  Daniela Buglio; Vidya Mamidipudi; Noor M Khaskhely; Helen Brady; Carla Heise; Jeffrey Besterman; Robert E Martell; Kyle MacBeth; Anas Younes
Journal:  Br J Haematol       Date:  2010-09-29       Impact factor: 6.998

2.  The lysine deacetylase inhibitor Givinostat inhibits β-cell IL-1β induced IL-1β transcription and processing.

Authors:  Mattias S Dahllöf; Dan P Christensen; Morten Lundh; Charles A Dinarello; Paolo Mascagni; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2012 Nov-Dec       Impact factor: 2.694

3.  The role of the liver X receptor in chronic obstructive pulmonary disease.

Authors:  Andrew Higham; Simon Lea; Jonathan Plumb; Barbara Maschera; Karen Simpson; David Ray; Dave Singh
Journal:  Respir Res       Date:  2013-10-12

Review 4.  Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases.

Authors:  Himavanth Reddy Gatla; Nethaji Muniraj; Prashanth Thevkar; Siddhartha Yavvari; Sahithi Sukhavasi; Monish Ram Makena
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

5.  Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition.

Authors:  Sandra G P J Korsten; Laura Peracic; Luka M B van Groeningen; Mara A P Diks; Herman Vromans; Johan Garssen; Linette E M Willemsen
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

6.  A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.

Authors:  A Rocca; S Minucci; G Tosti; D Croci; F Contegno; M Ballarini; F Nolè; E Munzone; A Salmaggi; A Goldhirsch; P G Pelicci; A Testori
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

7.  Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle.

Authors:  Se Jin Oh; Hyo-Jung Lee; Kwon-Ho Song; Suyeon Kim; Eunho Cho; Jaeyoon Lee; Marcus W Bosenberg; Tae Woo Kim
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.